Cardiomyopathy and Inherited Heart Muscle Disease
Kardigan Inc. focuses on symptomatic genetic and familial dilated cardiomyopathy, with research centered on the clinical burden of inherited cardiac muscle dysfunction and its impact on heart performance. The sponsor’s trial activity in this area reflects interest in conditions where structural and functional abnormalities of the heart lead to reduced efficiency and progressive symptoms.
- Dilated cardiomyopathy
- Genetic cardiomyopathy
- Familial heart disease
- Symptomatic cardiac impairment
Research in this field is directed toward improving understanding of heart function in patients with inherited disease patterns and persistent clinical symptoms.
Cardiac Function Assessment
The sponsor’s research includes evaluation of left ventricular performance and broader measures of cardiac function in affected participants. This area emphasizes clinical endpoints that capture how inherited cardiomyopathy influences the heart’s ability to pump effectively and maintain circulatory support.
- Transthoracic echocardiogram
- Heart pumping function
- Ventricular performance
- Cardiac structure and function
These interests align with monitoring changes in myocardial performance in patients living with progressive hereditary heart disease.
Exercise Capacity and Functional Status
Kardigan Inc. also studies exercise tolerance in participants with cardiomyopathy, reflecting attention to how cardiac disease affects physical performance and daily activity. This includes interest in objective measures of functional limitation in patients with symptomatic disease.
- Cardiopulmonary exercise testing
- Exercise performance
- Functional limitation
- Symptom-related exercise impairment
This therapeutic domain is closely tied to assessing the real-world impact of inherited heart disease on patient mobility and exertional capacity.
Cardiovascular Therapeutics
The sponsor’s clinical research includes investigation of danicamtiv in the setting of inherited dilated cardiomyopathy, indicating a strong therapeutic interest in treatments aimed at supporting compromised myocardial function. The research landscape is centered on cardiovascular disease management where improving heart performance is a key clinical objective.
- Myocardial support
- Inherited cardiovascular disease
- Heart failure-related symptoms
- Therapies for cardiomyopathy
Clinical activity in this area is concentrated in North America and multiple international research sites, with a focus on cardiovascular conditions affecting patients across diverse settings.
